Cnga3 | cyclic nucleotide gated channel alpha 3
Physiological systems
21 / 24 physiological systems tested
7 Significantly impacted by the knock-out
Homeostasis/metabolism Reproductive system Immune system Growth/size/body region Hematopoietic system Mortality/aging Renal/urinary system
14 No significant impact
3 Not tested
Data collections
Gene metrics:6Significant phenotypes
3Associated diseases
Expression examined in:73Adult tissues
0Embryo tissues
| preweaning lethality, incomplete penetrance | 1 supporting dataset | Cnga3tm1.1(KOMP)Vlcg | homozygote | Early adult | N/A * | ||
| increased circulating alanine transaminase level | 1 supporting dataset | Cnga3tm1.1(KOMP)Vlcg | homozygote | Early adult | 1.09x10-9 | ||
| enlarged spleen | 1 supporting dataset | Cnga3tm1.1(KOMP)Vlcg | heterozygote | Early adult | N/A * | ||
| decreased body length | 1 supporting dataset | Cnga3tm1.1(KOMP)Vlcg | homozygote | Early adult | 4.33x10-7 | ||
| abnormal kidney morphology | 1 supporting dataset | Cnga3tm1.1(KOMP)Vlcg | homozygote | Early adult | N/A * | ||
| enlarged uterus | 1 supporting dataset | Cnga3tm1.1(KOMP)Vlcg | heterozygote | Early adult | N/A * |
| | | | | | | | | | |
External links
No external links available for Cnga3.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.